Job title: Executive Director, Clinical Biomarkers & Diagnostics
Robert Loberg, PhD, leads a team of biomarker scientists and computational biologists in pursuit of biomarker and diagnostic driven drug development efforts across all therapeutic areas at Amgen. In addition, he leads an active lab-based research group charged with technology evaluation and biomarker discovery/implementation to support the biomarker needs of a growing pipeline. Dr. Loberg received his B.A. degree in biology from Baylor University and Ph.D. from The University of Michigan.